Ritlecitinib
Spécifications
1792180-81-4Numéro CAS
815-269-7Numéro CE
1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-oneNom IUPAC
C15H19N5OFormule chimique
285.34 g/molMasse molaire
ritlecitinib; 1792180-81-4; PF-06651600; 2OYE00PC25; 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one; 2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-; PF06651600; PF 06651600; 2-PROPEN-1-ONE, 1-((2S,5R)-2-METHYL-5-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-1-PIPERIDINYL)-; 1-((2S,5R)-2-methyl-5-((7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one; 1-((2S,5R)-2-methyl-5-(7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)piperidin-1-yl)prop-2-en-1-one; 1-[(2S,5R)-2-methyl-5-{7H-pyrrolo[2,3-d]pyrimidin-4-ylamino}piperidin-1-yl]prop-2-en-1-one; 1-{(2S,5R)-2-Methyl-5-[(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}prop-2-en-1-one; RefChem:179511; JAK3 Inhibitor PF-06651600; 815-269-7; 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one; 1-[(2S,5R)-5-[[7H-Pyrrolo[2,3-d]-4-pyrimidinyl]amino]-2-methyl-1-piperidyl]-2-propen-1-one; MFCD30343868; ritlecitinibum; PF-06651600 free base; MFCD31697544; RITLECITINIB [INN]; UNII-2OYE00PC25; RITLECITINIB [WHO-DD]; GTPL9559; orb1301838; CHEMBL4085457; SCHEMBL16764638; SCHEMBL24377696; SCHEMBL29369472; CHEBI:229233; DTXSID301356920; Ritlecitinib (PF-06651600); EX-A2613; AKOS040758742; example 5 [WO2015083028]; CCG-267324; DB14924; EBC-221083; compound 11 [PMID: 28139931]; NCGC00501213-04; AC-35550; BP-44053; BP168506; MS-24066; SY060486; RITLECITINIB (PF-06651600); DB-179694; HY-100754; CS-0020243; S8538; T5382; C91239; F980131; 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidyl]prop-2-en-1-oneSynonymes
